| 000 | 01550 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515014242.0 | ||
| 264 | 0 | _c20060524 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a1538-7933 | ||
| 024 | 7 |
_a10.1111/j.1538-7836.2006.01829.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAster, R H | |
| 245 | 0 | 0 |
_aThrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cMar 2006 |
||
| 300 |
_a678-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 | _aEptifibatide |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadverse effects |
| 650 | 0 | 4 |
_aPeptides _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThrombocytopenia _xblood |
| 650 | 0 | 4 | _aTirofiban |
| 650 | 0 | 4 |
_aTyrosine _xadverse effects |
| 700 | 1 | _aCurtis, B R | |
| 700 | 1 | _aBougie, D W | |
| 700 | 1 | _aDunkley, S | |
| 700 | 1 | _aGreinacher, A | |
| 700 | 1 | _aWarkentin, T E | |
| 700 | 1 | _aChong, B H | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 4 _gno. 3 _gp. 678-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1538-7836.2006.01829.x _zAvailable from publisher's website |
| 999 |
_c16073649 _d16073649 |
||